Nutra Pharma Corp.
Bringing Healthcare Solutions to the World
Medical Devices
Intellectual Property
Drug Development
R&D Pipeline
Nutra Pharma is developing an innovative pipeline of biopharmaceutical products
Signup to receive news and announcements from Nutra Pharma:
First Name:
Last Name:
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.


Nutra Pharma, through its medical devices subsidiary Designer Diagnostics, is taking on some of the world's most difficult diseases including Nontuberculous Mycobacteria (NTM) and Tuberculosis (TB)

Nontuberculous Mycobacteria (NTM)
Nontuberculous Mycobacteria (NTM), also known as atypical Tuberculosis (Atypical TB) or Mycobacterium other than Tuberculosis (MOTT), is a bacteria that is found in water, some domestic and wild animals, and soil. NTM is a primary cause of respiratory disease in humans and is a leading cause of death in HIV/AIDS patients.
Additional Information: Stop NTM Now
Tuberculosis (TB)

Tuberculosis (abbreviated as TB for Tubercle Bacillus) is a common and deadly infectious disease caused by the bacterium Mycobacterium tuberculosis, which most commonly affects the lungs (pulmonary TB) but can also affect the central nervous system, lymphatic system, circulatory system, genitourinary system, bones and joints.

Additional Information: Stop TB Now
Quick Nav
Nyloxin // Chronic Pain Relief
Read about Jeff Gottfurcht, the first rheumatoid arthritis sufferer to conquer Everest, in Musculoskeletal Health a special section of the Washington Post.


Recent News
September 14, 2016
Nutra Pharma Announces Manufacturing Alliance with Omnia Biologics to Produce RPI-78M for Clinical Trials in Pediatric Multiple Sclerosis

August 30, 2016
Nutra Pharma Announces Addition of Maj. Gen. Kenneth Dowd to its Advisory Board

August 16, 2016
Nutra Pharma Announces Additions to the Board of Directors and Management Team

Click here to view a Letter to Shareholders from the Company's CEO, Rik J Deitsch.
Facebook   Twitter
Privacy Policy Code of Ethics